Johnson & Johnson has agreed to pay over $2.5 Billion to settle thousands of lawsuits caused by defective all metal hip implants. However, the deal will not close unless a large majority of victims support the agreement.
The ASR implants were defective as a result of the metal parts grinding together and sloughing off metal...
Continue reading…
Category: Pharmaceutical
Backstory on whistleblowers who exposed Johnson & Johnson massive pharma fraud
Judith Doetteri and Camille McGowan, both little known sales representatives for Johnson & Johnson turned whistleblowers and are credited now with exposing the largest pharmaceutical fraud scheme ever resulting in payment of over $2.2 BILLION in civil and criminal fines.
For nine long years, Doetteri and McGowan kept their secret, working under cover with federal...
Continue reading…
Johnson & Johnson to pay $2.2 billion to settle federal charges of improper sales and kickbacks
Johnson & Johnson has agreed to pay more than $2.2 BILLION to resolve state and federal charges of improper selling of prescription drugs for uses other than approved uses by the FDA and for paying kickbacks to doctors and a pharmacy to increase sales.
The settlement is the largest of its kind for health care...
Continue reading…
Stryker medical device maker pays $13.2 million settling foreign bribe charges in whistleblower case
Stryker Corporation, a major manufacturer of medical devices will pay more than $13.2 million to resolve charges of violating the Foreign Corrupt Practices Act for paying bribes to foreign officials in Argentina, Greece, Mexico, Poland and Romania.
The bribes were paid in order to obtain approximately $7.5 million in gains.
The moneys were apparently paid by...
Continue reading…
Recipient of defective Guidant Pacemaker turns whistleblower forcing Boston Scientific to pay $30 million
James Allen, who received a defective pacemaker manufactured by Guidant LLC decided to blow the whistle on the company revealing information that two lines of implantable defibrillators were sold even though the company knew they were defective.
Boston Scientific and its subsidiaries Guidant LLC , Guidant Sales LLC and Cardiac Pacemakers Inc. will pay $30...
Continue reading…
Big Pharma companies pay increasing fines for off label drug promotion and Medicare fraud/kickbacks
Over the last ten years, major drug manufacturers have been caught promoting some of their medications to physicians for uses other than those uses approved by the FDA based on research and clinical studies. The act of promoting and marketing drugs for off label uses is illegal and its called "off-label promotion." The reason...
Continue reading…
PharMerica charged with dispensing drugs without physician prescriptions claims whistleblower
The pharmaceutical services firm PharMerica illegally dispensed controlled substances by dispensing drugs to nursing homes and facilities without physician authorized prescriptions, according to a complaint filed by the Department of Justice and whistleblower pharmacist Jennifer Denk.
Ms. Denk revealed the wrongdoing after she observed prescriptions including those for addictive drugs like fentanyl and oxycodone were...
Continue reading…
More investigations of bribes in China more possible charges : JP Morgan said to hire kids of officials Sanofi and Novartis alleged doc bribes
New and expanding allegations of corporate bribes in China have the Securities and Exchange Commission staff busy investigating possible violations of the Foreign Corrupt Practices Act and other laws and much of the information is coming from insider whistleblowers.
Chinese authorities announced an investigation of French drug manufacturer Sanofi SA over a whistleblower report accusing...
Continue reading…
Bribery commonplace and massive by foreign pharma firms in China
According to a BBC report, bribes are routinely paid by big pharmaceutical companies doing business in China and the new investigation of the GlaxosmithKline for alleged bribery has heightened international attention to the issue.
The BBC interviewed five drug salesman for foreign companies who told the reporters that their firms all paid bribes in order...
Continue reading…
Drugmakers use nursing home residents to push off label uses of drugs to defraud Medicare
Drugmakers have found a way to make more money by defrauding Medicare by marketing the off label uses of drugs to nursing home patients. This large group of helpless, hapless people can do nothing to stop being used as guinea pigs.
One example is Par Pharmaceuticals which paid $45 million this year to settle federal...
Continue reading…
